Results 1 to 10 of about 1,845 (139)
СТАТИН-ИНДУЦИРОВАННЫЕ МЕХАНИЗМЫ НАРУШЕНИЙ УГЛЕВОДНОГО ОБМЕНА
Žurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta, 2021 Статины – препараты первой линии, которые используются для профилактики сердечно-сосудистых заболеваний. Они снижают риск развития инфаркта миокарда, инсульта, а также сердечно-сосудистой смерти в среднем на 25-30%.
L. V. Nikonova +2 more
doaj +1 more source
RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS
Рациональная фармакотерапия в кардиологии, 2015 The cardiovascular risk factors in patients with rheumatoid arthritis (RA) are reviewed. The perspectives of treatments with statins in RA are given.
D. A. Anichkov, N. A. Shostak
doaj +1 more source
UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
Рациональная фармакотерапия в кардиологии, 2015 Early and aggressive treatment of patients with risk factors and clinically manifest cardiovascular diseases is one of the priorities of modern medicine.
N. F. Puchin'yan +2 more
doaj +1 more source
STATIN GENERICS: EFFICACY AND SAFETY RATIO
Рациональная фармакотерапия в кардиологии, 2016 Statin usage for primary and secondary prevention of cardiovascular diseases is focused. Rational choice between original and generic drugs is discussed taking into account efficacy and safety ratio.
V. P. Voronina +4 more
doaj +1 more source
Statins and liver. What's new?
Медицинский совет, 2013 Central obesity and two of the following four additional criteria are prerequisites of metabolic syndrome diagnosis: high triglyceride rate, low HDL, high blood pressure or high empty stomach glucose level (or previously diagnosed type 2 diabetes ...
O. M. Drapkina, M. V. Kostyukevich
doaj +1 more source
Влияние статинов на состояние эндотелия
University Therapeutic Journal, 2021 Статины активно внедряются в клиническую практику, поскольку позволяют существенно снизить риск развития и прогрессирования сердечно сосудистых заболеваний.
Кристина Александровна Лосева
doaj
Lipid-lowering therapy in the outpatient practice
Медицинский совет, 2013 The review focuses on the importance of primary and secondary prevention of cardiovascular disease in outpatient settings, and principles of effective and safe use of modern lipid-lowering drugs.
S. A. Urazgildeyeva
doaj +1 more source
Coronary heart disease and diabetes: diagnosis, medical and surgical treatment, prognosis (a review)
Медицинский совет, 2013 Th article tells about diagnosis, treatment and prognosis of stable coronary heart disease in patients with diabetes. Treatment with traditional drugs (β-blockers, statins, ACE inhibitors, antiplatelet agents) and surgical treatment (PCI, HB) aimed at ...
V. P. Lupanov
doaj +1 more source
Рациональная фармакотерапия в кардиологии, 2015 Aim. To assess of lipid-lowering therapy with statins in very high cardiovascular risk patients admitted to hospital for coronary angiography and analyze lipid profiles depending on the intensity of lipid-lowering therapy. Material and methods.
N. E. Gavrilova +4 more
doaj +1 more source
Евразийский Кардиологический Журнал, 2015 This review examines the possibility of personalized pharmacotherapy with statins, based on the genotype of the individual patient. Identification of polymorphism of genes, responsible for the metabolism of the liver CYP3A5, CYP2C9 and transport of ...
U. R. Makhmudova +4 more
doaj +1 more source